FDA approves Samsung Bioepis' copy of J & J's Remicade: company

SEOUL (Reuters) - South Korea's Samsung Bioepis Co Ltd said on Saturday the U.S. Food and Drug Administration approved its copy of Johnson& Johnson's rheumatoid arthritis drug Remicade, the first drug developed by the Samsung Group unit approved in the United States.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news